Preterm labor: clinical
management
Jana Skrzypczak
Jakub Kornacki
Division of Reproduction , University of Medical
Sciences, Poznań
Criteria for diagnosis of
preterm labor
1. Gestational age of 22-37 weeks
2. Documented uterine contractions ( at least 5-8
min apart and lasting 30 sec.)
3. Ruptured membranes
If membranes are intact at least one of the
following is needed:
• documented cervical changes
• cervical effacement of greater than 75%
• cervical dilatation of greater than 2 cm
Prediction of preterm
labor
Risk scoring
• previous preterm delivery
• low socioeconomic status
• short stature
• maternal age < 21 or > 36
years old
• multiple pregnancy
• vaginal bleeding
Risk scoring
Women with one previous preterm
delivery have a 15% chance and
those with two previous preterm
births have a 41 % chance of another
preterm delivery
Preterm labor
Maternal risk
The two most common maternal
condition associated with preterm birth
are:
- pregnancy induced
hypertension
- antepartum bleeding
Preterm labor
Maternal risk
• intrauterine infection (47%)
• placental abruption or placenta previa
(40%)
• uteroplacental insufficiency (
e.g.
hypertension , insulin dependent diabetes,
drug abuse, smoking, alcohol consumption)
• uterine factors (20%, e.g. fibroid uterus
)
Preterm labor
Maternal risk
• cervical incompetence (17%)
• immunological factors (33%)
• trauma ( surgical , others , 3%))
• idiopathic (1%)
Preterm labor
Fetal/ neonatal risk
• intrauterine fetal death
• intrauterine growth restriction
• major congenital anomalies
• repetitive variable decelerations
• absent or reversed diastolic flow in
Doppler examination of umbilical artery
• unrecognized intauterine infection
• complicated multiple pregnancy
Indications for delivery of a
preterm baby
• infection
• antepartum haemorrhage
• cardiotocographic fetal distress
• prolapsed cord
• failure of the fetus growth
• maternal consideration
Prediction of preterm
labor/delivery
• an increased frequency of baseline uterine
contractions
• cervix changes - shortening , softening and
progressive dilatation
• cytokines -increased concentration of IL-6 in
cervical and vaginal secretion
• fetal fibronectin increased concentration in
cervical and vaginal secretion
corticotropin releasing hormone - promotes
uterine
•
contractions
Diagnosis
• preterm onset of uterine contractions
• cervical changes
assesed by:
- transvaginal ultrasound
- visual inspection
- digital palpation
Differential diagnosis
• urinary tract infections
• small placental abruption or infarction
• degenerating fibromyomata
• appendicitis
• gastroenteritis
• hydramnios
• systemic febrile illneses ( malaria or
pneumonia)
Management
• hospital rest and sedation
The purposes of arresting the preterm
uterine contractions are:
-
to permit the administration of a course of
corticosteroids (48 hours)
- to prolong the pregnancy and gain fetal
maturity
Management
• monitoring uterine activity
• regular cervical assesments (clinical and
ultrasound)
• bacterial vaginal screening
All patients with preterm labor need
documentation of the presence or
absence of lower genital tract infection
In a population at risk for preterm
delivery
22% of preterm birth and
44% of cases with premature rupture
of membranes
were attributed to abnormal bacterial
colonization of the genital tract
Management
Tocolytic therapy
1. Magnesium sulfate
2. Indomethacin
3. Beta -sympathomimetics ( most
widely used)
4. Oxytocin inhibitor (Atosiban)
Management
Beta -sympathomimetics
Side effects
- cardiovascular ( increase in heart rate , a rise in
systolic pressure , a decrease in diastolic
pressure)
- elevation of plasma glucose
- decrease of plasma potasium level
A rare but more serious side effect is the
development of pulmonary edema ( 3 per 1000)
Management
•
Beta-sympathomimetics
•
Contraindications
• cardiac arythmia
• valvular disease
• ischemic heart disease
• heart malformation
• hyperthyreosis
Management
Indomethacin
is
reserved for cases of
preterm labor:
• before 32 weeks
• not responded to beta-sympathomemimetics
• with no clear evidence of intrauterine
infection
Loading dose of 50 mg orally or 100 mg rectally
followed by 25 mg orally every 4-6 hours for 24
-36 hours
Management
Indomethacin
Side effects
in the mother:
- gastrointestinal irritation and
bleeding
- trombocytopenia
- allergic reactions
Management
Indomethacin
Side effects
in the newborn :
- preterm closure of ductus arteriosus
- oligohydramnios
- periventricular leukomalacia ?
- necrotizing eneterocolitis (NEC) ?
Management
•
Indomethacin
•
Contraindications
•
peptic ulcer disease
• haemathological disorders
• oligohydramnios
• IUGR
Management
• Magnesium sulfate
the drug of
choice for patients with
diabetes
mellitus
and
heart disease
• Initial dose: 6 g ( 12 ml of 50% MgSO
4
in
100 ml 5% dextrose ) over 15-20 min
• Maintenance dose:1 g/h for 24-72 hours
• appropriate therapeutical level 5,5 -7 mg/dl
Management
• Magnesium sulfate
Complications respiratory depression
( at magnesium levels of 12 to 15
mg/dl)
• The antidote - calcium gluconate 1 g iv.
In 10% solution
• Contraindications: heart block, advanced
renal failure, myasthenia
Management
Calcium channel blockers
•Nifedypine
Cardiovascular side effects:
severe tachycardia and
hypotension ( in both the
mother and the neonate)
Assess for medical contraindications
to tocolysis
Use tocolysis with considerable caution
in patients with cardiac disease who
require medication or have a history of
congestive heart failure , cardiac
surgery , significant pulmonary disease ,
renal failure , or maternal infection (e.g.
pneumonia , appendicitis ,
pyelonephritis).In these cases , consult
with a maternal -fetal medicine
specialist prior to the initiation of
tocolysis
Management
Neonatal morbidity and mortality by
gestational age
Gestational
Age , wk
Survival Respiratory
Distress
Syndrome
Intraventricular
hemorrhage
Sepsis
Necrotizing
enterocolitis
Intact
24 40% 70% 25%
25% 8% 5%
25 70% 90% 30%
29% 17% 50%
26 75% 93% 30%
30% 11% 60%
27 80% 84% 16%
36% 10% 70%
28 90% 65% 4%
25% 25% 80%
Management
Neonatal morbidity and mortality by
gestational age
Gestational
Age , wk
Survival Respiratory
Distress
Syndrome
Intraventricular
hemorrhage
Sepsis
Necrotizing
enterocolitis
Intact
29 92% 53% 3%
25% 14% 85%
30 93% 55% 2%
11% 15% 90%
31 94% 37% 2%
14% 8% 93%
32 95% 28% 1%
3% 6% 95%
33 96% 34% 0%
5% 2% 96%
34 97% 14% 0%
4% 3% 97%
Management - fetal
therapy
Corticosteroids and other agents to
promote pulmonary maturation in
premature newborn
24-34 weeks gestation
• glucocorticoids
• thyroid releasing hormone (TRH)
• 50% decrease in the incidence of RDS
Fetal therapy
Betamethasone (Celestone)
at 12,5 mg every 24 hours
for 2 doses
Present recommendation
-single dose
Management
Glucocorticoids
• Theoretical risk
for the fetus:
- lower birth mass
- infections
- adrenal suppression
for the mother:
- infections
- pulmonary edema
( in combination
with
betasympathomimetics)
Mode of delivery
before 26 weeks
• careful discussion with
parents
• aim for vaginal delivery ;
experienced
pediatrician in attendance
Mode of delivery
after 26 weeks
• if cephalic presentation , aim for
vaginal
delivery with cesarean for normal
obsteric indications
• if breech presentation , aim for
cesarean
section